ON
Oxford Nanopore Technologies plc
ONTTF · OTC
$2.29 +12.81% (+$0.26)
1M +11.17%
Market Cap £1.67B
P/E Ratio -
Div. Yield -
ROE 29.12%
Bulios Fair Price
$1.24
45.9% downside
Current Price
$2.29
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ONTTF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
34 /100
Fair P/B 3.60x
P/S 7.45x
PEG N/A
Growth
31 /100
Declining Book val. growth 12.59%
Rev. growth 4.07%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 29.61%
Op. margin 69.36%
Gross margin 58.64%
Quality
5 /100
Poor Asset turnover 0.36x
ROA 23.33%
ROIC 31.62%
Debt
69 /100
Low Current ratio 3.56x
Int. coverage -55.46x
Debt/Equity 0.09x
Stability
56 /100
Moderate Profitable years 0
EPS volatility 48.59%
Beta 0.91x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ONTTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Francis Albert Luc Van Parys
Employees
1,403
Headquarters
Oxford
Upcoming events
09 MAR
Earnings
Upcoming earnings report